Skip to main content

What the FDA labels say about taking them together

Armodafinil and macimorelin

Macimorelin's FDA label of February 18, 2026 names armodafinil in its drug interactions section; the armodafinil label PlainMeds reads does not name macimorelin. The macimorelin label: “Cytochrome P450 (CYP) 3A4 Inducers Co-administration of a strong CYP3A4 inducer with MACRILEN may reduce the plasma macimorelin concentrations and may lead to false positive test results.”

Check it at the source: the armodafinil FDA label on DailyMed (effective September 2, 2025, Golden State Medical Supply, Inc.); the macimorelin FDA label on DailyMed (effective February 18, 2026, Aeterna Zentaris GmbH).

What does the armodafinil label say about macimorelin?

Armodafinil's label (effective September 2, 2025) does not name macimorelin in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Nuvigil), NDA021875 (Nuvo Pharms), as published by Golden State Medical Supply, Inc., effective September 2, 2025 (SPL set 3dd49302-f757-d945-e063-6294a90afcba), via openFDA; the full label on DailyMed

What does the macimorelin label say about armodafinil?

Macimorelin label, drug interactions

Cytochrome P450 (CYP) 3A4 Inducers Co-administration of a strong CYP3A4 inducer with MACRILEN (e.g., carbamazepine, enzalutamide, mitotane, phenytoin, rifampin, St. John's wort, bosentan, efavirenz, etravirine, modafinil, armodafinil, rufinamide) may reduce the plasma macimorelin concentrations and may lead to false positive test results.

Source: FDA drug label (Macrilen), Aeterna Zentaris GmbH, effective February 18, 2026 (SPL set aeb30f1a-4815-47ae-a2cb-b6b4e26372e1), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

7Armodafinil generic labelers
0Macimorelin generic labelers
ArmodafinilMacimorelin
Labeled forn/an/a
Boxed warningNoNo
Pharmacy cost (NADAC)$0.788 per tablet 150 mg tabletn/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?